The stem cell research center at UCSF got a major boost as it manage s to win a $25 million donation toward a new facility. UCSF officials announced to have received the donation from the Eli and Edythe Broad Foundation, a Los Angeles group that funds scientific and medical research.
Researchers claimed to have simplified the creation of so-called induced pluripotent stem (iPS) cells. Thus they have reduced the number of viruses in the reprogramming process from four to one.The Whitehead researchers are also hopeful of using the stem cell to treat various diseases.
Genzyme Corp. is looking for the FDA approval for its cancer drug Mozobil. The drug is expected to be announced in the market very soon. In a phase III trial, the combination of Mozobil and Amgen Inc.’s (AMGN) Neupogen was found to be better than Neupogen alone to mobilize and collect the optimal number of stem cells for bone-marrow transplants.
In yet another success in stem cell research, University of Pennsylvania scientists have found stem cell in the esophagus of mice are able to grow into tissue-like structures and when placed into immune-deficient mice were able to form parts of an esophagus lining.
You may call it the Obama effect or the recent success in stem cell research. For the first time in 21 years, the Vatican has finally gave its authoritative statement on reproductive science. Needless to say it triggers intense debate.
It can be called a breakthrough in stem cell research. Harvard researchers found some hematopoietic stem cells in bone marrow differentiate more slowly than others. The findings can revolutionize treatment for diseases such as leukemia, for which the only existing cure is bone marrow transplant.